Keywords: boeh, ingelheim, starts, mega-trials, germany, boehringer, initiated

Boeh Ingelheim starts two mega-trials

Article | 24 February 2003

Print This

Germany's Boehringer Ingelheim has initiated two major new clinicaltrial programs, one for its HIV drug tipranavir and another for Aggrenox/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in